Matches in DBpedia 2016-04 for { ?s ?p "RTA 408 is a second generation member of the synthetic oleanane triterpenoid compounds and currently in clinical development by Reata Pharmaceuticals. Preclinical studies have demonstrated that RTA 408 possesses antioxidative and anti-inflammatory activities and the ability to improve mitochondrial bioenergetics."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- RTA_408 comment "RTA 408 is a second generation member of the synthetic oleanane triterpenoid compounds and currently in clinical development by Reata Pharmaceuticals. Preclinical studies have demonstrated that RTA 408 possesses antioxidative and anti-inflammatory activities and the ability to improve mitochondrial bioenergetics.".
- Q21098900 comment "RTA 408 is a second generation member of the synthetic oleanane triterpenoid compounds and currently in clinical development by Reata Pharmaceuticals. Preclinical studies have demonstrated that RTA 408 possesses antioxidative and anti-inflammatory activities and the ability to improve mitochondrial bioenergetics.".